Company / Operating Cash Flow
Insulet Corporation Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$569.3M
FY2025
5-year range
-$68.1M / $569.3M
FY2021-FY2025
Trend
+32.3%
vs FY2024
Sector context
#49 of 158
Health Care
What the data says
At $569M, Insulet Corporation's operating cash flow ranks #49 of 158 in the Health Care sector. Operating Cash Flow has increased for 4 consecutive years, from -$68M in FY2021 to $569M in FY2025.
Based on SEC 10-K filings.
$569M in FY2025 with a 5-year CAGR of +46.6%.
Improved from $146M to $569M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +68.5%
- 5-Year CAGR
- +46.6%
- 10-Year CAGR
- -
Sector benchmark
#49 of 158 in Health CareTop 31% of 158This company $569.3M Sector average $1.0B
▼
-44.9% below sector average
Key checks
Key Insights
- Insulet Corporation's operating cash flow has grown for 4 consecutive years.
- 5-year CAGR of +46.6%, indicating consistent growth.
- In FY2025, operating cash flow increased 32.3% year-over-year.
- Ranks #49 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $569.3M | +32.3% |
| FY2024 | $430.2M | +195.3% |
| FY2023 | $145.7M | +22.4% |
| FY2022 | $119.0M | +274.7% |
| FY2021 | -$68.1M | -181.1% |
| FY2020 | $84.0M | -14.6% |
| FY2019 | $98.4M | +174.1% |
| FY2018 | $35.9M | -13.1% |
| FY2017 | $41.3M | +159.6% |
| FY2016 | $15.9M | +226.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026